Doxorubicin-loaded NaYF4: Yb/Tm-TiO2 inorganic photosensitizers for NIR-triggered photodynamic therapy and enhanced chemotherapy in drug-resistant breast cancers

Biomaterials

Volumn 57, Issue , 2015, Pages 93-106

  Zeng, Leyong ^a,b   Pan, Yuanwei ^a   Tian, Ying ^b   Wang, Xin ^b   Ren, Wenzhi ^a   Wang, Shouju ^b   Lu, Guangming ^b   Wu, Aiguo ^a  

^a NINGBO INSTITUTE OF MATERIALS TECHNOLOGY AND ENGINEERING   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Breast cancers; Enhanced chemotherapy; Multidrug resistance; NaYF4:Yb Tm TiO2 inorganic photosensitizers; NIR triggered photodynamic therapy

Indexed keywords

BIOCOMPATIBILITY; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DISEASES; INFRARED DEVICES; LASER EXCITATION; NANOCOMPOSITES; PHOTOSENSITIZERS; TARGETED DRUG DELIVERY; THULIUM ALLOYS; TITANIUM DIOXIDE;

BREAST CANCER; COMBINATION THERAPY; DEEP PENETRATION; MULTIDRUG RESISTANCE; PHOTODYNAMIC THERAPY (PDT); REACTIVE OXYGEN SPECIES; TOXICITY ASSESSMENT; UP-CONVERSION LUMINESCENCE;

PHOTODYNAMIC THERAPY;

DOXORUBICIN; FLUORIDE; FOLIC ACID; NANOCARRIER; NANOCOMPOSITE; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; SODIUM; SODIUM YTTRIUM FLUORIDE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; YTTRIUM; ANTINEOPLASTIC AGENT; SODIUM YTTRIUMTETRAFLUORIDE; THULIUM; TITANIUM; YTTERBIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGHT DAMAGE; LUMINESCENCE; MCF 7 CELL LINE; MOUSE; NANOPROBE; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; ANIMAL; BREAST; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; INFRARED RADIATION; NUDE MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUORIDES; HUMANS; INFRARED RAYS; MCF-7 CELLS; MICE, NUDE; NANOCOMPOSITES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; THULIUM; TITANIUM; YTTERBIUM; YTTRIUM;

EID: 84928946093     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.04.006     Document Type: Article

References (49)

1. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006, 5:219-234.
2. Gao Z., Zhang L., Sun Y. Nanotechnology applied to overcome tumor drug resistance. JControl Release 2012, 162:45-55.
3. Zhang X., Yang P., Dai Y., Ma P., Li X., Cheng Z., et al. Multifunctional up-converting nanocomposites with smart polymer brushes gated mesopores for cell imaging and thermo/pH dual-responsive drug controlled release. Adv Funct Mater 2013, 23:4067-4078.
4. Chen F., Hong H., Zhang Y., Valdovinos H.F., Shi S., Kwon G.S., et al. Invivo tumor targeting andimage-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. ACS Nano 2013, 7:9027-9039.
5. Wang C., Xu H., Liang C., Liu Y., Li Z., Yang G., et al. Iron oxide@polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano 2013, 7:6782-6795.
6. Kievit F.M., Wang F.Y., Fang C., Mok H., Wang K., Silber J.R., et al. Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer invitro. JControl Release 2011, 152:76-83.
7. 2 nanocarriers. RSC Adv 2013, 3:20855-20861.
8. Lee S.M., Kim H.J., Kim S.Y., Kwon M.K., Kim S., Cho A., et al. Drug-loaded gold plasmonic nanoparticles for treatment of multidrug resistance in cancer. Biomaterials 2014, 35:2272-2282.
9. Chen H., Zhang X., Dai S., Ma Y., Cui S., Achilefu S., et al. Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy. Theranostics 2013, 3:633-649.
10. Zhou T., Zhou X., Xing D. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier. Biomaterials 2014, 13:4185-4194.
11. Kim H., Lee D., Kim J., Kim T., Kim W.J. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano 2013, 7:6735-6746.
12. Li S., Hu K., Cao W., Sun Y., Sheng W., Li F., et al. pH-responsive biocompatible fluorescent polymer nanoparticles based on phenylboronic acid for intracellular imaging and drug delivery. Nanoscale 2014, 6:13701-13709.
13. Su J., Chen F., Cryns V.L., Messersmith P.B. Catechol polymer for pH-responsive, targeted drug delivery to cancer cell. JAm Chem Soc 2011, 133:11850-11853.
14. Yang Y., Pan D., Luo K., Li L., Gu Z. Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy. Biomaterials 2013, 34:8430-8443.
15. Qiu L., Qiao M., Chen Q., Tian C., Long M., Wang M., et al. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Biomaterials 2014, 35:9877-9887.
16. Deng Z., Yan F., Jin Q., Li F., Wu H., Liu X., et al. Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound. JControl Release 2014, 17:109-116.
17. Chien Y.H., Chou Y.L., Wang S.W., Huang S.T., Liau M.C., Chao Y.J., et al. Near-infrared light photocontrolled targeting bioimaging, and chemotherapy with caged upconversion nanoparticles invitro and invivo. ACS Nano 2013, 7:8516-8528.
18. Zhang F., Braun G.B., Pallaoro A., Zhang Y., Shi Y., Cui D.X., et al. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" naterials for targeted chemotherapy. Nano Lett 2012, 12:61-67.
19. Liu J., Bu W., Pan L., Zhang S., Chen F., Zhou L., et al. Simultaneous neclear imaging and intranuclear drug delivery by nuclear-targeted multifunctional upconversion nanoprobes. Biomaterials 2012, 33:7282-7290.
20. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
21. 3+ nanospheres for cell imaging and targeted anti-cancer drug delivery. Biomaterials 2013, 34:1601-1612.
22. Tsouris V., Joo M.K., Kim S.H., Kwon I.C., Won Y.Y. Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistance cancers. Biotechnol Adv 2014, 32:1037-1050.
23. Shen J., Wang Q., Hu Q., Li Y., Tang G., Chu P.K. Restoration of chemosensitivity by multifunctional micelles mediated by p-gp siRNA to reverse MDR. Biomaterials 2014, 35:8621-8634.
24. Chang Y., Yang K., Wei P., Huang S., Pei Y., Zhao W., et al. Cationic vesicles based on amphiphilic pillar[5]arene capped with ferrocenium: a redox-responsive system for drug/siRNA co-delivery. Angew Chem Int Ed 2014, 53:1-6.
25. Bhirde A.A., Chikkaveeraiah B.V., Srivatsan A., Niu G., Jin A.J., Kapoor A., et al. Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance. ACS Nano 2014, 8:4177-4189.
26. 2-weighted magnetic resonance/upconversion luminescence imaging and photodynamic therapy of cancer cells. RSC Adv 2013, 3:13915-13925.
27. Guo H., Qian H., Idris N.M., Zhang Y. Singlet oxygen-induced apoptosis of cancer cells using upconversion fluorescent nanoparticles as a carrier of photosensitizer. Nanomed-Nanotechnol 2010, 6:486-495.
28. Qiao X., Zhou J., Xiao J., Wang Y., Sun L., Yan C. Triple-functional core-shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy invitro. Nanoscale 2012, 4:4611-4623.
29. 2 nanoparticles for photocatalytic cancer-cell treatment. Small 2007, 3:850-853.
30. Rozhkova E.A., Ulasov I., Lai B., Dimitrijevic N.M., Lesniak M.S., Rajh T. Ahigh-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett 2009, 9:3337-3342.
31. Hu Z., Li J., Li C., Zhao S., Li N., Wang Y., et al. Folic acid-conjugated graphene-ZnO nanohybrid for targeting photodynamic therapy under visible light irradiation. JMater Chem B 2013, 1:5003-5013.
32. 2 nanocomposites for magnetic resonance imaging and potential photodynamic therapy. Nanoscale 2013, 5:2107-2113.
33. Zhang H., Chen B., Jiang H., Wang C., Wang H., Wang X. Astrategy for ZnO nanorod mediated multi-mode cancer treatment. Biomaterials 2011, 32:1906-1914.
34. 2 core/shell nanoparticles. Chem Commun 2010, 46:2304-2306.
35. 2 core-shell nanoparticles. ACS Catal 2013, 3:405-412.
36. 2 shells under mild conditions and their upconversion-based photocatalysis. Nanoscale 2013, 5:8930-8933.
37. 2 nanopowder. JPhys Chem C 2010, 114:13663-13669.
38. Idris N.M., Lucky S.S., Li Z., Huang K.H., Zhang Y. Photoactivation of core-shell titania coated upconversion nanoparticles and their effect on cell death. JMater Chem B 2014, 2:7017-7026.
39. Lucky S.S., Idris N.M., Li Z.Q., Huang K., Soo K.C., Zhang Y. Titania coated upconversion nanoparticles for near-infrared light triggered photodynamic therapy. ACS Nano 2015, 9:191-205.
40. 2 photosensitizing nanoplatform: near-infrared light mediated invivo photodynamic therapy via mitochondria-involved apoptosis pathway. ACS Nano 2015, 9:2584-2599.
41. Zhang L., Zeng L., Pan Y., Luo S., Ren W., Gong A., et al. Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for invivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers. Biomaterials 2015, 44:82-90.
42. Wei X., Wang W., Chen K. ZnO: Er, Yb, Gd particles designed for magnetic-fluorescent imaging and near-infrared light triggered photodynamic therapy. JPhys Chem C 2013, 117:23716-23729.
43. 4:Yb, Tm nanocomposite for near infrared-triggered drug release and enhanced targeted cancer cell ablation. Adv Healthc Mater 2012, 1:470-474.
44. 2 shell for near-infrared-triggered drug delivery and synergistic targeted cancer therapy. Chem Eur J 2014, 20:14012-14017.
45. Dinh C.T., Nguyen T.D., Kleitz F., Do T.O. Shape-controlled synthesis of highly crystalline titania nanocrystals. ACS Nano 2009, 3:3737-3743.
46. 3+ codoped amorphous fluoride film prepared by pulsed laser deposition. JAppl Phys 2003, 93:4328-4330.
47. Lv R., Yang P., He F., Gai S., Dai Y., Yang G., et al. Ayolk-like multifunctional platform for multimodal imaging and synergistic therapy triggered by a single near-infrared light. ACS Nano 2015, 9:1630-1647.
48. Carrasco E., Rosal B., Sanz-Rodríguez F., Fuente Á., Gonzalez P., Rocha U., et al. Intratumoral thermal reading during photo-thermal therapy by multifunctional fluorescent nanoparticles. Adv Funct Mater 2015, 25:615-626.
49. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002, 2:48-58.